Drug profile · INN
ustekinumab-hmny
STARJEMZA
ustekinumab-hmny (STARJEMZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Drug details — ustekinumab-hmny
- US status
- approved
- Class
- —
- Route
- SUBCUTANEOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ustekinumab-hmny (STARJEMZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is ustekinumab-hmny?
ustekinumab-hmny (STARJEMZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for ustekinumab-hmny?
STARJEMZA is a marketed brand name for ustekinumab-hmny. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ustekinumab-hmny?
ustekinumab-hmny has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.